Ayala Pharmaceuticals Inc

NASDAQ:AYLA   11:15:03 AM EDT
11.03
-0.17 (-1.52%)
Earnings Announcements

Ayala Pharmaceuticals Reports Q2 Loss Per Share of $0.75

Published: 08/13/2021 14:05 GMT
Ayala Pharmaceuticals Inc (AYLA) - Ayala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.75.
Q2 Earnings per Share Estimate $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0.84 Million
Adjusted EPS is expected to be -$0.80

Next Quarter Revenue Guidance is expected to be $0.97 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.